Posttransplant adoptive immunotherapy with interleukin-2 in children suffering from neuroectodermal tumors with poor prognosis

Transplant Proc. 2002 Mar;34(2):665-7. doi: 10.1016/s0041-1345(01)02881-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Bone Marrow Transplantation / immunology*
  • Busulfan / therapeutic use
  • Child
  • Child, Preschool
  • Cytotoxicity, Immunologic
  • Gene Amplification
  • Genes, myc
  • Humans
  • Immunotherapy, Adoptive*
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Natural / immunology
  • Melphalan / therapeutic use
  • Neuroectodermal Tumors / therapy*
  • Platelet Count
  • Prognosis
  • Sequence Deletion
  • Treatment Outcome

Substances

  • Interleukin-2
  • Busulfan
  • Melphalan